SEQENS, based in Paris is an integrated pharmaceutical synthesis and specialty ingredients producer. The company was established in 2019 following the acquisition of PCAS and other companies by the Novacap group.
For organic electronic applications, SEQENS offers evaporable small molecules, transparent electrode materials, active conductive polymers, smart luminescent polymers and substrate materials.
BP 181 - 23 Rue Bossuet
Z.I. La Vigne aux Loups
91160 Longjumeau
France
